Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | CFTR | P13569 | 1/20 | 0.50 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | NAMPT | P43490 | 3/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14053150 | 1.00 | FDPS (0.51) | FDPSNPC1RAB9APKMCFTR | |
| SCHEMBL30340371 | 0.86 | NPC1 (0.50) | FDPSNPC1RAB9APKMCFTR | |
| SCHEMBL29416376 | 0.86 | NPC1 (0.50) | FDPSNPC1RAB9APKMCFTR | |
| SCHEMBL3996687 | 0.83 | CYP1A2 (0.62) | FDPSNPC1RAB9APKMCFTR | |
| SCHEMBL3488827 | 0.81 | MME (0.45) | RAB9ACYP3A4EPHX2ALDH1A1LMNA | |
| SCHEMBL344918 | 0.81 | MME (0.45) | RAB9ACYP3A4EPHX2ALDH1A1LMNA | |
| SCHEMBL344919 | 0.81 | MME (0.45) | RAB9ACYP3A4EPHX2ALDH1A1LMNA | |
| SCHEMBL8581194 | 0.80 | MMP2 (0.45) | FDPSNPC1RAB9APKMCFTR | |
| SCHEMBL31052770 | 0.80 | FDPS (0.44) | FDPSNPC1RAB9APKMCFTR | |
| SCHEMBL30998137 | 0.80 | FDPS (0.44) | FDPSNPC1RAB9APKMCFTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106543017-B | A kind of preparation method of 4 aminocyclohexyl acetic acid | 中国科学院青岛生物能源与过程研究所 | 2018-04-06 | — | — | CN | disclosed |
| CN-106543017-B | A kind of preparation method of 4 aminocyclohexyl acetic acid | 中国科学院青岛生物能源与过程研究所 | 2018-04-06 | — | — | CN | disclosed |
| US-20170172957-A1 | D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | ALLERGAN, INC. | 2017-06-22 | — | — | US | disclosed |
| EP-2714029-B1 | D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | ALLERGAN INC (US) | 2017-04-12 | — | — | EP | disclosed |
| CN-106543017-A | A kind of preparation method of 4 aminocyclohexyl acetic acid | 中国科学院青岛生物能源与过程研究所 | 2017-03-29 | — | — | CN | disclosed |
| CN-106543017-A | A kind of preparation method of 4 aminocyclohexyl acetic acid | 中国科学院青岛生物能源与过程研究所 | 2017-03-29 | — | — | CN | disclosed |
| US-9415031-B2 | D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders | ALLERGAN, INC. (US) | 2016-08-16 | — | — | US | disclosed |
| US-20140221453-A1 | D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VISUAL SYSTEM DISORDERS | ALLERGAN, INC. (US) | 2014-08-07 | — | — | US | disclosed |
| CN-103946686-A | Long rigid spacers to enhance binding kinetics in immunoassays | KONINKL PHILIPS NV | 2014-07-23 | — | — | CN | disclosed |
| CN-103930783-A | Particle repulsion to enhance surface contact in magnetic particle immunoassays | KONINKL PHILIPS ELECTRONICS NV | 2014-07-16 | — | — | CN | disclosed |
| US-8741955-B2 | D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders | ALLERGAN, INC. (US) | 2014-06-03 | — | — | US | disclosed |
| US-8735451-B2 | D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders | ALLERGAN, INC. (US) | 2014-05-27 | — | — | US | disclosed |
| US-20120329851-A1 | D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | ALLERGAN, INC. | 2012-12-27 | — | — | US | disclosed |
| WO-2012166533-A1 | D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VISUAL SYSTEM DISORDERS | ALLERGAN, INC. (US) | 2012-12-06 | — | — | WO | disclosed |
| WO-2012166544-A1 | D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | ALLERGAN, INC. (US) | 2012-12-06 | — | — | WO | disclosed |
| US-20120302621-A1 | D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VISUAL SYSTEM DISORDERS | ALLERGAN, INC. | 2012-11-29 | — | — | US | disclosed |